Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

The delay dovetails with moves by Republican lawmakers in at least 7 states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal approval ...

A person familiar with the situation told CNN that the FDA is seeking more data on the vaccine, which has been available under emergency use authorization since 2022. It was the first Covid-19 ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency's regulatory ...

Novavax's traditional protein-based COVID shot offers an alternative technology to messenger RNA-based rivals from Pfizer-BioNTech and Moderna, but has failed to make a mark in the U.S. vaccine market ...

A top FDA official directly intervened in an agency review of Novavax’s Covid-19 vaccine, pausing the approval process to ask for more data on the shot, according to four people familiar with ...

Former top U.S. health official Anthony Fauci has received both criticism and support on social media following the White House's launch of a website which accused him of pushing a narrative about the ...

Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...

Fox News contributor Dr. Marty Makary was officially confirmed to lead the FDA in Trump's second administration after a vote on Tuesday night.